electroCore, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ECOR Nasdaq 3841 https://www.electrocore.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for electroCore, Inc.

electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England - Oct 20th, 2021 12:00 pm
electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine - Oct 14th, 2021 12:00 pm
electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance - Oct 12th, 2021 12:00 pm
electroCore Announces Acceptance of Motion to Dismiss in the Federal Court Securities Class Action Suit - Oct 7th, 2021 12:00 pm
36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021 - Oct 4th, 2021 8:30 pm
electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference - Sep 30th, 2021 1:05 pm
electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients - Sep 29th, 2021 12:00 pm
2 “Strong Buy” Penny Stocks That Are Headed to a Triple-Digit Gain - Sep 23rd, 2021 2:50 pm
electroCore to Participate at Upcoming Investor Conferences - Sep 23rd, 2021 12:00 pm
electroCore Announces Peter Cuneo as Board Chairman - Sep 20th, 2021 12:00 pm
electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Paroxysmal Hemicrania and Hemicrania Continua - Sep 14th, 2021 12:00 pm
electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference - Aug 31st, 2021 12:00 pm
electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC. - Aug 24th, 2021 12:00 pm
electroCore (NASDAQ:ECOR) Is In A Good Position To Deliver On Growth Plans - Aug 16th, 2021 11:21 am
Study of Non-Invasive Vagus Nerve Stimulation (nVNS) Shows Improvement in PTSD Symptoms and Decreased Inflammatory Response to Stress - Aug 10th, 2021 12:00 pm
ECOR: Impressive Growth: Invigorating Guidance - Aug 9th, 2021 10:23 am
electroCore Announces Second Quarter 2021 Financial Results - Aug 5th, 2021 8:01 pm
electroCore to Present at the Canaccord Genuity Growth Conference - Aug 2nd, 2021 12:00 pm
ElectroCore Stock Is Trading Higher As Ladenburg Initiates Coverage With $3 Price Target, Buy Rating - Jul 27th, 2021 12:50 pm
electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones - Jul 27th, 2021 12:00 pm